These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 19841102)
1. A two-step intensity-modulated radiation therapy method for nasopharyngeal cancer: the Kinki University experience. Nishimura Y; Shibata T; Nakamatsu K; Kanamori S; Koike R; Okubo M; Nishikawa T; Tachibana I; Tamura M; Okumura M Jpn J Clin Oncol; 2010 Feb; 40(2):130-8. PubMed ID: 19841102 [TBL] [Abstract][Full Text] [Related]
2. Intensity-modulated radiation therapy without concurrent chemotherapy for stage IIb nasopharyngeal cancer. Tham IW; Lin S; Pan J; Han L; Lu JJ; Wee J Am J Clin Oncol; 2010 Jun; 33(3):294-9. PubMed ID: 20395788 [TBL] [Abstract][Full Text] [Related]
3. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience. Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834 [TBL] [Abstract][Full Text] [Related]
4. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175 [TBL] [Abstract][Full Text] [Related]
5. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience. de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451 [TBL] [Abstract][Full Text] [Related]
6. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma. Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420 [TBL] [Abstract][Full Text] [Related]
7. Aichi cancer center initial experience of intensity modulated radiation therapy for nasopharyngeal cancer using helical tomotherapy. Kodaira T; Tomita N; Tachibana H; Nakamura T; Nakahara R; Inokuchi H; Fuwa N Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1129-34. PubMed ID: 18922651 [TBL] [Abstract][Full Text] [Related]
8. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma]. Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674 [TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma. Kim K; Wu HG; Kim HJ; Sung MW; Kim KH; Lee SH; Heo DS; Kim HJ; Park CI Head Neck; 2009 Sep; 31(9):1121-8. PubMed ID: 19340863 [TBL] [Abstract][Full Text] [Related]
10. Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre singapore experience. Tham IW; Hee SW; Yeo RM; Salleh PB; Lee J; Tan TW; Fong KW; Chua ET; Wee JT Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1481-6. PubMed ID: 19386431 [TBL] [Abstract][Full Text] [Related]
11. Preliminary results of a phase I/II study of simultaneous modulated accelerated radiotherapy for nondisseminated nasopharyngeal carcinoma. Lee SW; Back GM; Yi BY; Choi EK; Ahn SD; Shin SS; Kim JH; Kim SY; Lee BJ; Nam SY; Choi SH; Kim SB; Park JH; Lee KK; Park SH; Kim JH Int J Radiat Oncol Biol Phys; 2006 May; 65(1):152-60. PubMed ID: 16472934 [TBL] [Abstract][Full Text] [Related]
13. Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma. Kwong DL; Sham JS; Leung LH; Cheng AC; Ng WM; Kwong PW; Lui WM; Yau CC; Wu PM; Wei W; Au G Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):374-81. PubMed ID: 16213105 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma. Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654 [TBL] [Abstract][Full Text] [Related]
15. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series. Lin S; Pan J; Han L; Zhang X; Liao X; Lu JJ Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1071-8. PubMed ID: 19362784 [TBL] [Abstract][Full Text] [Related]
16. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord. Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826 [TBL] [Abstract][Full Text] [Related]
17. A phase II study of adaptive two-step intensity-modulated radiation therapy (IMRT) with chemotherapy for loco-regionally advanced nasopharyngeal cancer (JCOG1015). Nishimura Y; Ishikura S; Shibata T; Kodaira T; Ito Y; Tsuchiya K; Murakami Y; Saitoh JI; Akimoto T; Nakata K; Yoshimura M; Teshima T; Toshiyasu T; Ota Y; Ishikawa K; Shimizu H; Minemura T; Nakamura K; Hiraoka M Int J Clin Oncol; 2020 Jul; 25(7):1250-1259. PubMed ID: 32221802 [TBL] [Abstract][Full Text] [Related]
18. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck. McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794 [TBL] [Abstract][Full Text] [Related]
19. IMRT with simultaneous integrated boost and concurrent chemotherapy for nasopharyngeal cancer: plan evaluation and treatment outcome. Kim JW; Cho JH; Keum KC; Kim JH; Kim GE; Lee JY; Kim SK; Lee CG Jpn J Clin Oncol; 2012 Dec; 42(12):1152-60. PubMed ID: 23077243 [TBL] [Abstract][Full Text] [Related]
20. Phase II study: concurrent chemo-radiotherapy in advanced nasopharyngeal carcinoma. Maoleekoonpairoj S; Phromratanapongse P; Puttanuparp S J Med Assoc Thai; 1997 Dec; 80(12):778-84. PubMed ID: 9470331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]